Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004561,
umls-concept:C0017262,
umls-concept:C0037993,
umls-concept:C0054941,
umls-concept:C0085862,
umls-concept:C0185117,
umls-concept:C0330390,
umls-concept:C0376315,
umls-concept:C0439682,
umls-concept:C1299583,
umls-concept:C1413207,
umls-concept:C1515021,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1711368,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
1998-8-27
|
pubmed:abstractText |
We have used multicolor FACS analysis, immunohistology, and functional assays to study the expression of CD1 on B cell subsets from normal and beta 2m-/- mice. Two B cell subpopulations were identified that express high levels of CD1 in normal mice: splenic marginal zone B cells (IgMhigh IgDlow CD21high CD24intermediate CD23- CD43-) and a newly identified subpopulation of follicular B cells. The latter cells are unusual, because they are IgDhigh CD23+, like follicular B cells, but express high levels of CD21 and IgM, an expression pattern that is associated with marginal zone B cells. Therefore, the high-level expression of CD1 and CD21 was found to be closely associated on splenic B cells. Immunohistology confirmed the expression of CD1 on marginal zone B cells and on clusters of B cells in splenic follicles. Both the high-level CD1 expression by these cells and the low-level CD1 expression by subpopulations of B cells in the spleen, lymph node, peritoneal cavity, and bone marrow were markedly reduced in beta 2m-/- mice. Despite this, a CD1-restricted T cell clone proliferated vigorously in response to LPS-activated spleen cells that had been obtained from both beta 2m-/- and wild-type mice. This response was inhibited by the 3C11 anti-CD1 mAb. These results show the heterogeneity of B cell subsets in their expression of the beta 2m-dependent form of CD1. They further suggest that a beta 2m-independent form of CD1 is expressed on B cells that can stimulate T cells; however, this form is not easily visualized with the anti-CD1 mAb used here.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
161
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1710-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9712035-Animals,
pubmed-meshheading:9712035-Antigens, CD1,
pubmed-meshheading:9712035-B-Lymphocyte Subsets,
pubmed-meshheading:9712035-Cell Line,
pubmed-meshheading:9712035-Female,
pubmed-meshheading:9712035-Immunophenotyping,
pubmed-meshheading:9712035-Lymphocyte Activation,
pubmed-meshheading:9712035-Male,
pubmed-meshheading:9712035-Mice,
pubmed-meshheading:9712035-Mice, Inbred BALB C,
pubmed-meshheading:9712035-Mice, Inbred C57BL,
pubmed-meshheading:9712035-Mice, Knockout,
pubmed-meshheading:9712035-Organ Specificity,
pubmed-meshheading:9712035-Spleen,
pubmed-meshheading:9712035-T-Lymphocyte Subsets,
pubmed-meshheading:9712035-beta 2-Microglobulin
|
pubmed:year |
1998
|
pubmed:articleTitle |
CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms.
|
pubmed:affiliation |
Department of Medicine, Stanford University School of Medicine, CA 94305-5111, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|